We then extended this observation to the in vivo xenograft tumor model derived from MDA-MB-231 cells after shRNA-based knockdown of ASCT2 or SPOP or both (Fig. 6h) and found that consistent with cell culture model, ASCT2 knockdown inhibited, whereas SPOP knockdown promoted tumor growth. The gene discussed is SLC1A5; the disease is neoplasm.